We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Whistleblower Suit Accusing Bayer of Defrauding DoD Allowed to Proceed
Whistleblower Suit Accusing Bayer of Defrauding DoD Allowed to Proceed
October 18, 2013
A federal appeals court Oct. 15 said a former Bayer employee will be allowed to proceed with a whistleblower lawsuit accusing the drugmaker of defrauding the Department of Defense (DoD) into buying mass quantities of its cholesterol drug Baycol.